Impact of select actionable genomic alterations on efficacy of neoadjuvant immunotherapy in resectable non-small cell lung cancer. - Zhou N; Leung CH; William WN Jr; Weissferdt A; Pataer A; Godoy MCB; Carter BW; Fossella FV; Tsao AS; Blumenschein GR; Le X; Zhang J; et al. (Journal for immunotherapy of cancer, 2024)